Around Campus
Synthetic lymph node brings new fight to cancer care
March 16, 2026
A dime-sized technology from Carolina-affiliated startup Persistence Therapeutics could transform CAR-T therapy, turning today’s costly and weeks-long cancer treatment into a simpler, more affordable procedure that targets many cancer types and can be done at almost any hospital.
Rethinking the future of fibrosis
March 9, 2026
The College’s Ronit Freeman and SOM’s James Hagood are challenging one of medicine’s most deeply rooted assumptions: that fibrosis is permanent and irreversible.
Low-wage workers face instability across age groups
March 2, 2026
School of Social Work professor Mat Despard recently examined low-wage worker trends across the country, finding that just 28% of their jobs can be considered stable and secure.
A new metric for monitoring lung health
February 26, 2026
SOM researchers have developed a tool to identify airway mucus abnormalities in patients with chronic bronchitis, chronic obstructive pulmonary disease, or asthma before symptoms start.
Microscopic animals use mitochondrial signal to survive extreme stressÂ
February 9, 2026
Chemistry researchers in the College study how microscopic creatures called tardigrades survive osmotic stress — sudden changes in cellular moisture — to improve cell preservation, engineer more resilient crops, and even design safer cancer treatments.
Advancing genetic treatment for pediatric epilepsy
February 6, 2026
Erin Heinzen, a professor in the School of Pharmacy, studies the genetic causes of epilepsy and other neurodevelopmental disorders to develop new therapies for children with severe, drug-resistant seizures.
Study revisits groundbreaking project on early childcare and education
February 6, 2026
A new mixed methods study by the FPG Child Development Institute will assess the Abecedarian Project to highlight which elements of the program were most impactful.
Innovating the future of esophageal research
February 5, 2026
SOM’s Evan Dellon and NC State’s Anthony Blikslager are developing animal models of esophageal diseases to give scientists a new and efficient way to investigate these conditions.
New combination therapy could revolutionize treatments for brain cancer
February 5, 2026
A team led by SOM’s Aziz Sancar discovered that combining a common chemotherapy drug with a chemical called EdU provided unprecedented survival and cancer remission in various preclinical glioblastoma models.
UNC Dataverse recognized as a trustworthy data repositoryÂ
February 4, 2026
UNC Dataverse, an institutional data repository for UNC researchers, has been recognized by the CoreTrustSeal, highlighting commitment to proper stewardship and upholding the highest standards.